Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739752 · ClinicalTrials.gov registry record · NA
Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,747
- Enrollment target
NCT00739752: Completed NA study, sponsored by Indiana University.
NCT00739752 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,747 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00739752, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,747 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate two sets of interventions to increase acceptance of hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD) clinics. The 1st set of interventions, with 3 levels, is based on message framing. The 3 levels are: 1. information only; 2. gain-framed message; and 3. loss-framed message. The 2nd set of interventions, with 2 levels, involves how the vaccine is recommended by the health care provider. The 2 levels are: 1. HBV vaccine offered; and 2. HBV vaccine recommended. The outcome of interest is1st dose acceptance.
Primary Outcome
Mean Number of HBV vaccine doses received over an 8-month period, including the clinic visit. Count values ranged from 0 to 3 doses.
Interventions
- BEHAVIORAL Non-Framed-Offered
- BEHAVIORAL Non-Framed-Recommended
- BEHAVIORAL Gain-Framed-Offered
- BEHAVIORAL Gain-Framed-Recommended
- BEHAVIORAL Loss-Framed-Offered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,747 participants |
| Start Date | 2003-06 |
| Est. Completion | 2007-10 |
| Phase | NA |
What the finished NCT00739752 record still lists
NCT00739752 is an interventional study that assigns participants to a tested intervention. Its 1,747 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% higher).
The record links to 0 conditions, and to 5 interventions - of which Non-Framed-Offered is the first listed.
NCT00739752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00739752 about?
NCT00739752 is a clinical study titled "Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics". The goal of this study is to evaluate two sets of interventions to increase acceptance of hepatitis B virus (HBV) vaccination in patients attending sexually transmitted disease (STD) clinics. The 1st set of interventions, with 3 levels, is based on message framing. The 3 levels are: 1. information o...
What is the current status of trial NCT00739752?
This trial is currently completed. It is a NA study. The enrollment target is 1,747 participants. The study started on 2003-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00739752?
The interventions under investigation include: Non-Framed-Offered (BEHAVIORAL), Non-Framed-Recommended (BEHAVIORAL), Gain-Framed-Offered (BEHAVIORAL), Gain-Framed-Recommended (BEHAVIORAL), Loss-Framed-Offered (BEHAVIORAL).
Who is sponsoring clinical trial NCT00739752?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00739752's enrollment target sits among peer trials
1,747 62nd of 2000 higher than 1,939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- NCT06954337 · 1,750 participants · NA
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- NCT07183527 · 1,750 participants · NA
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia